Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2019, Article ID 5376439, 13 pages
https://doi.org/10.1155/2019/5376439
Research Article

Fushiming Capsule Attenuates Diabetic Rat Retina Damage via Antioxidation and Anti-Inflammation

1Department of Chinese Material Medical and Natural Medicines, Fourth Military Medical University, Xi’an, Shaanxi 710032, China
2Center of Clinical Aerospace Medicine, Fourth Military Medical University, Xi’an, Shaanxi 710032, China
3Department of Pharmacy, Central Hospital of Ankang City, Ankang 725000, Shaanxi, China
4Xi’an Lejian Biological Technology Co., Ltd., Xi’an 710032, Shaanxi, China
5Academic Journals Publishing Center of Education Department, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, Shaanxi, China

Correspondence should be addressed to Siwang Wang; nc.ude.ummf@wisgnaw and Hongling He; moc.361@90.lhh

Received 26 January 2019; Accepted 21 March 2019; Published 18 July 2019

Guest Editor: José C. T. Carvalho

Copyright © 2019 Mengshan He et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. D. Solomon, E. Chew, E. J. Duh et al., “Diabetic retinopathy: A position statement by the American Diabetes Association,” Diabetes Care, vol. 40, no. 3, pp. 412–418, 2017. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Muc, A. Saracen, and I. Grabska-Liberek, “Associations of diabetic retinopathy with retinal neurodegeneration on the background of diabetes mellitus. Overview of recent medical studies with an assessment of the impact on healthcare systems.,” Open Medicine (Poland), vol. 13, no. 1, pp. 130–136, 2018. View at Publisher · View at Google Scholar · View at Scopus
  3. W. R. Rowley, C. Bezold, Y. Arikan, E. Byrne, and S. Krohe, “Diabetes 2030: insights from yesterday, today, and future trends,” Population Health Management, vol. 20, no. 1, pp. 6–12, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. M. E. Hartnett, W. Baehr, and Y. Z. Le, “Diabetic retinopathy, an overview,” Vision Research, vol. 139, pp. 1–6, 2017. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Lee, T. Y. Wong, and C. Sabanayagam, “Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss,” Eye and Vision, vol. 2, article 17, 2015. View at Google Scholar
  6. M. Whitehead, S. Wickremasinghe, A. Osborne, P. Van Wijngaarden, and K. R. Martin, “Diabetic retinopathy: a complex pathophysiology requiring novel therapeutic strategies,” Expert Opinion on Biological Therapy, vol. 18, pp. 1–14, 2018. View at Google Scholar
  7. C. Hernández, A. Simó-Servat, P. Bogdanov, and R. Simó, “Diabetic retinopathy: new therapeutic perspectives based on pathogenic mechanisms,” Journal of Endocrinological Investigation, vol. 40, no. 9, pp. 925–935, 2017. View at Publisher · View at Google Scholar · View at Scopus
  8. X. Huimin, Z. Qiao, H. Yue, L. Yang, Z. Mingke, and W. Siwang, “Study on quality standard for fushiming capsule,” Journal of China Pharmacy, vol. 29, pp. 749–753, 2018. View at Google Scholar
  9. K. H. Wong, G. Q. Li, K. M. Li, V. Razmovski-Naumovski, and K. Chan, “Kudzu root: traditional uses and potential medicinal benefits in diabetes and cardiovascular diseases,” Journal of Ethnopharmacology, vol. 134, no. 3, pp. 584–607, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. J. K. Prasain, N. Peng, R. Rajbhandari, and J. M. Wyss, “The Chinese Pueraria root extract (Pueraria lobata) ameliorates impaired glucose and lipid metabolism in obese mice,” Phytomedicine, vol. 20, no. 1, pp. 17–23, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Cai, X. Zhang, X. Xu, and Y. Yu, “Effects of puerarin on the retina and STAT3 expression in diabetic rats,” Experimental and Therapeutic Medicine, vol. 14, pp. 5480–5484, 2017. View at Google Scholar
  12. J. Kim, K. M. Kim, C.-S. Kim et al., “Puerarin inhibits the retinal pericyte apoptosis induced by advanced glycation end products in vitro and in vivo by inhibiting NADPH oxidase-related oxidative stress,” Free Radical Biology & Medicine, vol. 53, no. 2, pp. 357–365, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Teng, H. Cui, M. Yang et al., “Protective effect of puerarin on diabetic retinopathy in rats,” Molecular Biology Reports, vol. 36, no. 5, pp. 1129–1133, 2009. View at Publisher · View at Google Scholar
  14. X. X. M. W. Zhu, “The effect of puerarin against IL-1 β -mediated leukostasis and apoptosis in retinal capillary endothelial cells (TR-iBRB2),” Molecular Vision, vol. 20, pp. 1815–1823, 2014. View at Google Scholar · View at Scopus
  15. C. Fernández-Moriano, E. González-Burgos, I. Iglesias, R. Lozano, and M. P. Gómez-Serranillos, “Evaluation of the adaptogenic potential exerted by ginsenosides Rb1 and Rg1 against oxidative stress-mediated neurotoxicity in an in vitro neuronal model,” PLoS ONE, vol. 12, no. 8, Article ID e182933, 2017. View at Google Scholar · View at Scopus
  16. J. Wee, K. Park, and A. Chung, Biological Activities of Ginseng and Its Application to Human Health, 2011.
  17. W. Chao, Y. Hong, M. Chen, and B. Lin, “Inhibitory effects of Angelica sinensis ethyl acetate extract and major compounds on NF-kappaB trans-activation activity and LPS-induced inflammation,” Journal of Ethnopharmacology, vol. 129, no. 2, pp. 244–249, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Tasneem, B. Liu, B. Li, M. I. Choudhary, and W. Wang, “Molecular pharmacology of inflammation: Medicinal plants as anti-inflammatory agents,” Pharmacological Research, vol. 139, pp. 126–140, 2019. View at Publisher · View at Google Scholar
  19. W.-L. Wei, R. Zeng, C.-M. Gu, Y. Qu, and L.-F. Huang, “Angelica sinensis in China-A review of botanical profile, ethnopharmacology, phytochemistry and chemical analysis,” Journal of Ethnopharmacology, vol. 190, pp. 116–141, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. Bu, L. Lv, X. Li, C. Chu, and S. Tong, “pH-zone-refining elution–extrusion countercurrent chromatography: separation of hydroxyanthraquinones from Cassiae semen,” Journal of Separation Science, vol. 40, no. 21, pp. 4281–4288, 2017. View at Publisher · View at Google Scholar · View at Scopus
  21. Q. Chen, Z. Xu, P. Yu, and P. Cen, “Advances in biochemical study of active anthraquinone constituents in Chinese traditional herb semen Cassiae,” Zhong Yao Cai, vol. 25, no. 6, pp. 442–445, 2002. View at Google Scholar · View at Scopus
  22. S. Li, Q. Li, X. Lv et al., “Aurantio-obtusin relaxes systemic arteries through endothelial PI3K/AKT/eNOS-dependent signaling pathway in rats,” Journal of Pharmacological Sciences, vol. 128, no. 3, pp. 108–115, 2015. View at Publisher · View at Google Scholar · View at Scopus
  23. K. S. Kwon, J. H. Lee, K. S. So et al., “Aurantio-obtusin, an anthraquinone from cassiae semen, ameliorates lung inflammatory responses,” Phytotherapy Research, vol. 32, no. 8, pp. 1537–1545, 2018. View at Publisher · View at Google Scholar · View at Scopus
  24. F. Lin, C. Zhang, X. Chen et al., “Chrysophanol affords neuroprotection against microglial activation and free radical-mediated oxidative damage in BV2 murine microglia,” International Journal of Clinical and Experimental Medicine, vol. 8, no. 3, pp. 3447–3455, 2015. View at Google Scholar · View at Scopus
  25. J. Zhang, C. L. Yan, S. Wang, Y. Hou, G. P. Xue, and L. Zhang, “Chrysophanol attenuates lead exposure-induced injury to hippocampal neurons in neonatal mice,” Neural Regeneration Research, vol. 9, no. 9, pp. 924–930, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. C. Shen, J. Jiang, L. Yang, D. Wang, and W. Zhu, “Anti-ageing active ingredients from herbs and nutraceuticals used in traditional Chinese medicine: pharmacological mechanisms and implications for drug discovery,” British Journal of Pharmacology, vol. 174, pp. 1395–1425, 2016. View at Publisher · View at Google Scholar
  27. X. Chu, S. Zhou, R. Sun et al., “Chrysophanol relieves cognition deficits and neuronal loss through inhibition of inflammation in diabetic mice,” Neurochemical Research, vol. 43, no. 4, pp. 972–983, 2018. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Lian, X. Xia, H. Zhao, and Y. Zhu, “The potential of chrysophanol in protecting against high fat-induced cardiac injury through Nrf2-regulated anti-inflammation, anti-oxidant and anti-fibrosis in Nrf2 knockout mice,” Biomedicine & Pharmacotherapy, vol. 93, pp. 1175–1189, 2017. View at Publisher · View at Google Scholar · View at Scopus
  29. L. Tang, Y. Zhang, Y. Jiang et al., “Dietary wolfberry ameliorates retinal structure abnormalities in db/db mice at the early stage of diabetes,” Experimental Biology and Medicine, vol. 236, no. 9, pp. 1051–1063, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. C.-K. Hu, Y.-J. Lee, C. M. Colitz, C.-J. Chang, and C.-T. Lin, “The protective effects of Lycium barbarum and Chrysanthemum morifolum on diabetic retinopathies in rats,” Veterinary Ophthalmology, vol. 15, no. 2, pp. 65–71, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Voabil, J. Liberal, E. C. Leal et al., “Calcium dobesilate is protective against inflammation and oxidative/nitrosative stress in the retina of a type 1 diabetic rat model,” Ophthalmic Research, vol. 58, no. 3, pp. 150–161, 2017. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Sevin and J. F. Cuendet, “Five years' experimentation with calcium dobesilate in the treatment of retinopathies,” Ophthalmologica, vol. 170, no. 2-3, pp. 232–238, 1975. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Roy, T. S. Kern, B. Song, and C. Stuebe, “Mechanistic insights into pathological changes in the diabetic retina: implications for targeting diabetic retinopathy,” The American Journal of Pathology, vol. 187, no. 1, pp. 9–19, 2017. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Karbasforooshan and G. Karimi, “The role of SIRT1 in diabetic retinopathy,” Biomedicine & Pharmacotherapy, vol. 97, pp. 190–194, 2018. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Brownlee, “The pathobiology of diabetic complications: a unifying mechanism,” Diabetes, vol. 54, no. 6, pp. 1615–1625, 2005. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Kubota, Y. Ozawa, T. Kurihara et al., “Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation,” Investigative Ophthalmology & Visual Science, vol. 52, no. 12, pp. 9142–9148, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. M. Mizutani, C. Gerhardinger, and M. Lorenzi, “Muller cell changes in human diabetic retinopathy,” Diabetes, vol. 47, no. 3, pp. 445–449, 1998. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Lieth, A. J. Barber, B. Xu et al., “Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy,” Diabetes, vol. 47, no. 5, pp. 815–820, 1998. View at Publisher · View at Google Scholar · View at Scopus
  39. H. F. Dvorak, L. F. Brown, M. Detmar, and A. M. Dvorak, “Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis,” The American Journal of Pathology, vol. 146, no. 5, pp. 1029–1039, 1995. View at Google Scholar · View at Scopus
  40. X. Chen, L. Wang, Y. Wu et al., “Effect of puerarin in promoting fatty acid oxidation by increasing mitochondrial oxidative capacity and biogenesis in skeletal muscle in diabetic rats,” Nutrition & Diabetes, vol. 8, no. 1, 2018. View at Publisher · View at Google Scholar
  41. W. Yan, P. Long, T. Chen et al., “A natural occurring mouse model with adgrv1 mutation of usher syndrome 2C and characterization of its recombinant inbred strains,” Cellular Physiology and Biochemistry, vol. 47, no. 5, pp. 1883–1897, 2018. View at Publisher · View at Google Scholar · View at Scopus
  42. M. He, P. Long, W. Yan et al., “ALDH2 attenuates early-stage STZ-induced aged diabetic rats retinas damage via Sirt1/Nrf2 pathway,” Life Sciences, vol. 215, pp. 227–235, 2018. View at Publisher · View at Google Scholar
  43. N. Pescosolido, A. Barbato, A. Stefanucci, and G. Buomprisco, “Role of electrophysiology in the early diagnosis and follow-up of diabetic retinopathy,” Journal of Diabetes Research, vol. 2015, Article ID 319692, 8 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  44. C. D. Luu, J. A. Szental, S.-Y. Lee, R. Lavanya, and T. Y. Wong, “Correlation between retinal oscillatory potentials and retinal vascular caliber in type 2 diabetes,” Investigative Ophthalmology & Visual Science, vol. 51, no. 1, pp. 482–486, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. D. L. McCulloch, M. F. Marmor, M. G. Brigell et al., “ISCEV Standard for full-field clinical electroretinography (2015 update),” Documenta Ophthalmologica, vol. 130, pp. 1–12, 2015. View at Google Scholar · View at Scopus
  46. C. Gustavsson, C.-D. Agardh, A. V. Zetterqvist, J. Nilsson, E. Agardh, and M. F. Gomez, “Vascular cellular adhesion molecule-1 (VCAM-1) expression in mice retinal vessels is affected by both hyperglycemia and hyperlipidemia,” PLoS ONE, vol. 5, no. 9, Article ID e12699, pp. 1–12, 2010. View at Publisher · View at Google Scholar · View at Scopus
  47. T. Khalfaoui, G. Lizard, and A. Ouertani-Meddeb, “Adhesion molecules (ICAM-1 and VCAM-1) and diabetic retinopathy in type 2 diabetes,” Journal of Molecular Histology, vol. 39, no. 2, pp. 243–249, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. V. Asnaghi, C. Gerhardinger, T. Hoehn, A. Adeboje, and M. Lorenzi, “A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat,” Diabetes, vol. 52, no. 2, pp. 506–511, 2003. View at Publisher · View at Google Scholar · View at Scopus
  49. A. K. H. Cheung, M. K. L. Fung, A. C. Y. Lo et al., “Aldose reductase deficiency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of mice,” Diabetes, vol. 54, no. 11, pp. 3119–3125, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. A. Araszkiewicz and D. Zozulinska-Ziolkiewicz, “Retinal neurodegeneration in the course of diabetes-pathogenesis and clinical perspective,” Current Neuropharmacology, vol. 14, no. 8, pp. 805–809, 2016. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Wang, E. Xu, M. H. Elliott, M. Zhu, and Y.-Z. Le, “Müller cell-derived VEGF is essential for diabetes-induced retinal inflammation and vascular leakage,” Diabetes, vol. 59, no. 9, pp. 2297–2305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. A. M. Joussen, V. Poulaki, M. L. Le et al., “A central role for inflammation in the pathogenesis of diabetic retinopathy,” The FASEB Journal, vol. 18, no. 12, pp. 1450–1452, 2004. View at Publisher · View at Google Scholar · View at Scopus
  53. J. Fehér, S. Taurone, M. Spoletini et al., “Ultrastructure of neurovascular changes in human diabetic retinopathy,” International Journal of Immunopathology and Pharmacology, vol. 31, Article ID 1042259236, 2017. View at Google Scholar · View at Scopus
  54. O. Simó-Servat, C. Solà-Adell, P. Bogdanov, C. Hernández, and R. Simó, “Mechanisms of retinal neuroprotection of calcium dobesilate: therapeutic implications,” Neural Regeneration Research, vol. 12, no. 10, pp. 1620–1622, 2017. View at Publisher · View at Google Scholar · View at Scopus
  55. Y. Zhou, J. Yuan, C. Qi, X. Shao, S. Mou, and Z. Ni, “Calcium dobesilate may alleviate diabetes-induced endothelial dysfunction and inflammation,” Molecular Medicine Reports, vol. 16, no. 6, pp. 8635–8642, 2017. View at Publisher · View at Google Scholar · View at Scopus
  56. U. Förstermann and W. C. Sessa, “Nitric oxide synthases: regulation and function,” European Heart Journal, vol. 33, no. 7, pp. 829–837, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Sharma, S. Saxena, K. Srivastav et al., “Nitric oxide and oxidative stress is associated with severity of diabetic retinopathy and retinal structural alterations,” Clinical & Experimental Ophthalmology, vol. 43, no. 5, pp. 429–436, 2015. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Kulaksizoglu and A. Karalezli, “Aqueous humour and serum levels of nitric oxide, malondialdehyde and total antioxidant status in patients with type 2 diabetes with proliferative diabetic retinopathy and nondiabetic senile cataracts,” Canadian Journal of Diabetes, vol. 40, no. 2, pp. 115–119, 2016. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Mehrzadi, M. Motevalian, M. Rezaei Kanavi, I. Fatemi, H. Ghaznavi, and M. Shahriari, “Protective effect of melatonin in the diabetic rat retina,” Fundamental & Clinical Pharmacology, vol. 32, no. 4, pp. 414–421, 2018. View at Publisher · View at Google Scholar · View at Scopus
  60. J. Xu, L.-J. Chen, J. Yu et al., “Involvement of advanced glycation end products in the pathogenesis of diabetic retinopathy,” Cellular Physiology and Biochemistry, vol. 48, no. 2, pp. 705–717, 2018. View at Publisher · View at Google Scholar · View at Scopus
  61. G. R. Barile, S. I. Pachydaki, S. R. Tari et al., “The RAGE axis in early diabetic retinopathy,” Investigative Ophthalmology & Visual Science, vol. 46, no. 8, pp. 2916–2924, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. J. K. Prasain, K. Jones, N. Brissie, R. Moore, J. M. Wyss, and S. Barnes, “Identification of puerarin and its metabolites in rats by liquid chromatography-tandem mass spectrometry,” Journal of Agricultural and Food Chemistry, vol. 52, no. 12, pp. 3708–3712, 2004. View at Publisher · View at Google Scholar · View at Scopus
  63. G. Zheng, L. Lin, S. Zhong, Q. Zhang, and D. Li, “Effects of puerarin on lipid accumulation and metabolism in high-fat diet-fed mice,” PLoS ONE, vol. 10, no. 3, Article ID e0122925, 2015. View at Publisher · View at Google Scholar · View at Scopus